Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Cue Biopharma, Inc. market cap for the quarter ending 2026-08-12 was $220.8M, a 250.36% increase year-over-year.
Cue Biopharma, Inc. market cap for the quarter ending 2026-06-30 was $164.99M, a 212.87% increase year-over-year.
Cue Biopharma, Inc. market cap for the quarter ending 2026-05-12 was $119.39M, a 93.12% decline year-over-year.
Cue Biopharma, Inc. market cap for the quarter ending 2026-03-31 was $722,689.70, a 99.96% decline year-over-year.
Cue Biopharma, Inc. market cap for fiscal 2026 was $220.8M.
Cue Biopharma, Inc. market cap for fiscal 2025 was $981,993.56, a 99.95% decline from fiscal 2024.
Cue Biopharma, Inc. market cap for fiscal 2024 was $2.02B, a 45.94% decline from fiscal 2023.
Cue Biopharma, Inc. market cap for fiscal 2023 was $3.74B, a 7.37% decline from fiscal 2022.